Zhang Haohao, Wang Xueying, Zhang Jing, He Yixuan, Yang Xiumin, Nie Yongzhan, Sun Lijuan
Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education. School of Medicine, Northwest University, Xi'an, Shaaxi Province, China.
State Key Laboratory of Targeting Oncology, National Center for International Re-search of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
J Transl Int Med. 2023 Dec 20;11(4):382-392. doi: 10.2478/jtim-2023-0123. eCollection 2023 Dec.
Macrophages residing in the gut maintain gut homeostasis by orchestrating patho-gens and innocuous antigens. A disturbance in macrophages leads to gut inflamma-tion, causing conditions such as inflammatory bowel disease (IBD). Macrophages ex-hibit remarkable plasticity, as they are sensitive to various signals in the tissue micro-environment. During the recent decades, gut microbiota has been highlighted refer-ring to their critical roles in immunity response. Microbiome-derived metabolites and products can interact with macrophages to participate in the progression of IBD. In this review, we describe recent findings in this field and provide an overview of the current understanding of microbiota-macrophages interactions in IBD, which may lead to the development of new targets and treatment options for patients with IBD.
驻留在肠道中的巨噬细胞通过协调病原体和无害抗原维持肠道内稳态。巨噬细胞功能紊乱会导致肠道炎症,引发诸如炎症性肠病(IBD)等病症。巨噬细胞表现出显著的可塑性,因为它们对组织微环境中的各种信号敏感。在最近几十年中,肠道微生物群因其在免疫反应中的关键作用而受到关注。微生物群衍生的代谢产物和产物可与巨噬细胞相互作用,参与IBD的进展。在这篇综述中,我们描述了该领域的最新发现,并概述了目前对IBD中微生物群与巨噬细胞相互作用的理解,这可能会为IBD患者带来新靶点和治疗选择的发展。